Success in drug discovery starts with the right strategic choices—selecting the optimal target, matching the right modality, guiding chemistry direction, and prioritizing risk.
Malamas Consulting brings deep medicinal chemistry expertise to every decision, combining scientific rigor with practical, actionable insights. We help advance programs efficiently, maximizing progress while managing risk effectively.
The Value Proposition
Engaging Dr. Malamas means aligning scientific innovation with disciplined execution — accelerating the path from target hypothesis to clinical candidate with clarity, rigor, and measurable progress.
Outcome: Faster, de-risked decisions, investor-ready data, and programs built to advance into the clinic — maximizing Cost–Time–Value at every stage.
Michael Malamas, PhD, is a senior medicinal chemistry consultant, drug discovery expert, and PMP-certified project leader with more than 30 years of experience spanning global pharmaceuticals, venture-backed biotechnology, academia, and government-funded research.
He advises biotech companies, startups, and research organizations on translating scientific innovation into scalable, milestone-driven drug discovery strategies—from target validation through clinical candidate nomination.
Dr. Malamas has held leadership roles including Medicinal Chemist, Project Leader, Senior Director, Vice President, Senior Advisor, and Research Professor. Throughout his career, he has built and led high-performing, multidisciplinary teams and has been accountable for multiple development candidates advancing into clinical trials across diverse therapeutic areas.
His therapeutic expertise spans oncology, Alzheimer’s disease, schizophrenia, diabetes, obesity, estrogen biology, pain management, eating disorders, infectious and antiviral diseases, as well as inflammatory disorders
Dr. Malamas began his career at Wyeth in Princeton, New Jersey, where over two decades he advanced into senior leadership positions and contributed to the delivery of multiple development and clinical candidates. He later transitioned to academia at Northeastern University, where he led translational research programs and mentored emerging scientists. He subsequently joined the biotechnology sector in Boston, contributing to innovative discovery programs at Cellarity and BAKX Therapeutics.
In the public sector, Dr. Malamas has supported NIH- and U.S. Army–funded anti-infective and antiviral programs, integrating medicinal chemistry, structural biology, computational modeling, and DMPK into cohesive development strategies.
He is widely recognized for his expertise in:
- Medicinal chemistry and structure-based drug design
- Structural biology and computational modeling
- Portfolio and program strategy
- Lead optimization and candidate readiness
- Data-driven, milestone-focused execution
Dr. Malamas collaborates closely with global academic partners and CRO organizations to ensure rigorous, capital-efficient advancement of drug discovery programs. He has authored or co-authored more than 200 peer-reviewed publications, patents, and book chapters, reflecting a sustained commitment to scientific innovation and therapeutic impact.
Malamas Consulting 